Table of Contents
or identify any additional material weaknesses, the accuracy and timing of our financial reporting may be adversely affected, we may be unable to maintain compliance with securities law
requirements regarding timely filing of periodic reports in addition to applicable stock exchange listing requirements, investors may lose confidence in our financial reporting, and our stock price
may decline as a result.
After this offering, our executive officers, directors and principal stockholders will maintain the
ability to control all matters submitted to stockholders for approval.
Assuming the sale by us of 4,250,000 shares of common stock in this offering (or 4,887,500 shares if the underwriters
exercise their option to purchase additional shares in full), our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock before this offering will, in
the aggregate, beneficially own shares representing approximately 35.7% of our capital stock. Assuming an initial public offering price of $20.00 per share, which is the midpoint of the price range
set forth on the cover page of this prospectus, if certain of our significant stockholders and their affiliated entities purchase all the shares they have indicated an interest in purchasing in this
offering, the number our executive officers, directors and stockholders who owned more than 5% of our outstanding common stock before this offering will, in the aggregate, beneficially own shares
representing approximately 44.0% of our capital stock. As a result, if these stockholders were to act together, they would be able to control all matters submitted to our stockholders for approval, as
well as our management and affairs. For example, these persons, if they act together, would control the election of directors and approval of any merger, consolidation or sale of all or substantially
all of our assets. This concentration of voting power could delay or prevent an acquisition of our company on terms that other stockholders may desire or result in management of our company that our
public stockholders disagree with.
A significant portion of our total outstanding shares are restricted from immediate resale but may
be sold into the market in the near future, which could cause the market price of our common stock to drop significantly, even if our business is performing well.
Sales of a substantial number of shares of our common stock in the public market could occur at any time, subject to certain
restrictions described below. These sales, or the perception in the market that holders of a large number of shares intend to sell shares, could reduce the market price of our common stock. After this
offering, we will have outstanding 21,900,603 shares of common stock based on the number of shares outstanding as of September 30, 2015. This includes the 4,250,000 shares that we
are selling in this offering, which may be resold in the public market immediately without restriction, unless purchased by our affiliates. The remaining 17,650,603 shares are currently
restricted as a result of securities laws or lock-up agreements but will be able to be sold after the offering as described in the "Shares Eligible for Future Sale" and "Underwriting" sections of this
prospectus. Moreover, after this offering, holders of an aggregate of approximately 17,350,044 shares of our common stock will have rights, subject to some conditions, to require us to file
registration statements covering their shares or to include their shares in registration statements that we may file for ourselves or other stockholders. We intend to register all shares of common
stock that we may issue under our equity compensation plans. Once we register these shares, they can be freely sold in the public market upon issuance, subject to volume limitations applicable to
affiliates and the lock-up agreements described in the "Underwriting" section of this prospectus.
Certain of our significant stockholders and their affiliated entities have indicated an interest in purchasing an aggregate of up to $30 million of shares of common stock in this
offering at the initial public offering price. Any such shares purchased by these stockholders who are considered to be our affiliates could not be resold in the public market immediately following
this offering as a result of restrictions under securities laws, but would be able to be sold following the expiration of these restrictions as described in the "Shares Eligible for Future Sale"
section of this prospectus.